Lisata jumps on FDA orphan drug status for liver cancer drug Source: Seekingalpha
Browsing: cancer
HUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in China Source: Seekingalpha
NuCana plunges after trial setback for cancer drug Source: Seekingalpha
HUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in China Source: Seekingalpha
NuCana plunges after trial setback for cancer drug Source: Seekingalpha
HUTCHMED pulls regulatory submission for Takeda-partnered cancer drug in China Source: Seekingalpha
NuCana plunges after trial setback for cancer drug Source: Seekingalpha
Merck stops two more cancer trials over poor results Source: Seekingalpha
Nuvectis gains on FDA’s orphan drug designation for cancer therapy Source: Seekingalpha
Roman Didkivskyi Siemens Healthineers (OTCPK:SEMHF) is wanting to pay greater than €200M ($224M) to purchase a Novartis (NYSE:NVS) business targeted on producing radioactive chemical compounds for…